WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
4
WUHAN LAND
830779
5
TECHVISION
832876
CN Stock MarketDetailed Quotes
600713 Nanjing Pharmaceutical
- 4.90
- +0.03+0.62%
Market Closed Feb 27 15:00 CST
6.42BMarket Cap11.06P/E (TTM)
4.91High4.83Low94.18KlotVolume4.86Open4.87Pre Close45.88MTurnover0.72%Turnover Ratio11.11P/E (Static)1.31BShares5.6452wk High0.96P/B6.38BFloat Cap4.0652wk Low5.36Limit Up1.30BShs Float19.62Historical High4.38Limit Down1.64%Amplitude-0.27Historical Low0.16Dividend TTM4.87Avg Price33.61KlotAsk3.27%Div YieldTTM100Lot Size59.06KlotBid
Nanjing Pharmaceutical News
Nanjing Pharmaceutical\'s announcement on the listing and circulation of restricted non-public shares in 2021
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan was granted for the first time to release part of the second restricted stock release and listing announcement
Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan granted part of the second share release and listing announcement for the lifting of sales restrictions
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on the company\'s 2021 Restricted Stock Incentive Plan for the first time to grant part of the second period of lifting the sales restriction period and the achievement of lifting the sales restriction conditions
Nanjing Pharmaceutical: Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the company\'s 2021 restricted stock incentive plan granted part of the second sales restriction period to lift the sales restriction list for the first time
Nanjing Pharmaceutical: Legal Opinion from the Shanghai Branch of Beijing Jingtian Gongcheng Law Firm on the Company\'s 2021 Restricted Stock Incentive Plan for the First Time Granting Part II of the Sales Restriction Period and the Achievement of Lifting the Conditions of Cancellation of Sales Restrictions
Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan granted part of the second sales restriction period to lift the sales restriction list for the first time
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the Company\'s 2021 Restricted Stock Incentive Plan for the First Time Granting Part 2 of the Sales Restriction Period and Achievements in Releasing the Conditions of Sale Restriction
Announcement of Nanjing Pharmaceutical on the Company\'s 2021 Restricted Stock Incentive Plan for the first time and the achievement of lifting sales restrictions during the second period of lifting sales restrictions
Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first stock release and listing announcement for the lifting of sales restrictions
Nanjing Pharmaceutical: Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first sales restriction period to lift the sales restriction list
Nanjing Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing Jingtian Gongcheng Law Firm on Nanjing Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Reserve Grants Part 1 of the Achievements of Lifting the Conditions of Cancellation of the Sales Restriction Period
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on the company\'s 2021 Restricted Stock Incentive Plan reserves and grants some of the first results to lift the sales restrictions during the period of lifting the sales restrictions
Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first sales restriction period to lift the sales restriction list
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on Nanjing Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Reserve Grants Part 1 of the First Release Period to Lift Sales Restriction Conditions
Nanjing Pharmaceutical\'s announcement on the Company\'s 2021 Restricted Stock Incentive Plan to reserve and grant part of the first achievement of lifting the sales restriction conditions during the period of lifting the sales restrictions
Announcement of Implementation of Annual Equity Distribution of Nanjing Pharmaceutical in 2023.
Announcement on the Adjustment of Cash Dividends for 2023 Annual Profit Distribution by Nanjing Pharmaceutical
Nanjing Pharmaceutical's stock-based incentive restricted share buyback cancellation implementation announcement.
Legal opinion of Beijing Jingtian Gongcheng Law Firm on the implementation of the repurchase cancellation of restricted stocks in Nanjing Pharmaceutical Co., Ltd.'s 2021 restricted stock incentive plan.